- David Chang to hand over the reins at Allogene; Ex-Esperion CEO gets started at PhlowLongtime Allogene CEO David Chang will be stepping down at the end of June. Chang has served as the company’s CEO for the past eight years and will be succeeded by ...Endpoints · 1mo ago↗ source
- Pfizer strikes Innovent deal worth up to $10.5B for a dozen cancer programsOn the eve of this year’s ASCO annual meeting, Pfizer said it is teaming up with China’s Innovent Biologics to advance a portfolio of 12 early-stage antibody-drug conjugates and multi-specific anti…Endpoints · 1mo ago↗ source
- Lilly obesity meds Foundayo and Zepbound to gain CVS coverageEli Lilly’s flagship obesity medications will be included in CVS Caremark formularies, likely boosting sales in the most competitive commercial drug market. The company announced Thursday that it…